The management of rheumatic diseases in pregnancy
- PMID: 20337545
- PMCID: PMC3724464
- DOI: 10.3109/03009740903449313
The management of rheumatic diseases in pregnancy
Abstract
Pregnancy can create a challenge for physicians caring for women with rheumatic diseases. For many women with rheumatoid arthritis (RA), pregnancy can provide a reprieve from long-term joint pain and inflammation, but others will not experience remission and will continue to need medication. Systemic lupus erythematosus (SLE) may remain quiet in some women, but in others may become more aggressive during pregnancy, putting both mother and foetus at risk. Women with limited scleroderma can do remarkably well, but scleroderma renal crises can be difficult to manage. A third of pregnancies in women with antiphospholipid syndrome (APS) may be refractory to our best therapy. In general, active inflammation from rheumatic diseases poses a stronger threat to the well-being of both mother and foetus than many immunosuppressant medications. Therefore, continued immunosuppression with the least risky medications will allow for the most optimal pregnancy outcomes.
Similar articles
-
Pregnancy in patients with rheumatic diseases: obstetric management and monitoring.Lupus. 2004;13(9):696-8. doi: 10.1191/0961203303lu1090oa. Lupus. 2004. PMID: 15485106
-
State of the art: Reproduction and pregnancy in rheumatic diseases.Autoimmun Rev. 2015 May;14(5):376-86. doi: 10.1016/j.autrev.2014.12.011. Epub 2014 Dec 30. Autoimmun Rev. 2015. PMID: 25555818 Review.
-
Molecular mechanisms in normal pregnancy and rheumatic diseases.Clin Exp Rheumatol. 2006 Nov-Dec;24(6):707-12. Clin Exp Rheumatol. 2006. PMID: 17207391 Review.
-
Pregnancy outcomes in women with rheumatic diseases: a real-world observational study in Japan.Lupus. 2019 Oct;28(12):1407-1416. doi: 10.1177/0961203319877258. Epub 2019 Sep 24. Lupus. 2019. PMID: 31551035
-
Pregnancy and Management in Women with Rheumatoid Arthritis, Systemic Lupus Erythematosus, and Obstetric Antiphospholipid Syndrome.Med Clin North Am. 2021 Mar;105(2):341-353. doi: 10.1016/j.mcna.2020.10.002. Med Clin North Am. 2021. PMID: 33589107 Review.
Cited by
-
Adverse birth outcomes and early-life infections after in utero exposure to corticosteroids for inflammatory bowel disease: a Danish nationwide cohort study.BMC Med. 2023 Apr 12;21(1):140. doi: 10.1186/s12916-023-02817-7. BMC Med. 2023. PMID: 37046314 Free PMC article.
-
Racial disparities in pregnancy outcomes among women with rheumatic diseases: A systematic literature review.Semin Arthritis Rheum. 2023 Jun;60:152193. doi: 10.1016/j.semarthrit.2023.152193. Epub 2023 Mar 22. Semin Arthritis Rheum. 2023. PMID: 36966601 Free PMC article.
-
Sex Differences in Biological Systems and the Conundrum of Menopause: Potential Commonalities in Post-Menopausal Disease Mechanisms.Int J Mol Sci. 2022 Apr 8;23(8):4119. doi: 10.3390/ijms23084119. Int J Mol Sci. 2022. PMID: 35456937 Free PMC article. Review.
-
Differences in the Association Between Oral Glucocorticoids and Risk of Preterm Birth by Data Source: Reconciling the Results.Arthritis Care Res (Hoboken). 2022 Aug;74(8):1332-1341. doi: 10.1002/acr.24865. Epub 2022 May 20. Arthritis Care Res (Hoboken). 2022. PMID: 35089649 Free PMC article.
-
Preterm birth is strongly affected by the glucocorticoid dose during pregnancy in women complicated by systemic lupus erythematosus.Arthritis Res Ther. 2022 Jan 3;24(1):10. doi: 10.1186/s13075-021-02699-1. Arthritis Res Ther. 2022. PMID: 34980235 Free PMC article.
References
-
- Petri M, Allbritton J. Fetal outcome of lupus pregnancy: a retrospective case-control study of the Hopkins Lupus Cohort. J Rheumatol. 1993;20:650–6. - PubMed
-
- Steen VD, Medsger TA., Jr Fertility and pregnancy outcome in women with systemic sclerosis. Arthritis Rheum. 1999;42:763–8. - PubMed
-
- Katz PP. Childbearing decisions and family size among women with rheumatoid arthritis. Arthritis Rheum. 2006;55:217–23. - PubMed
-
- Sanchez-Guerrero J, Uribe AG, Jimenez-Santana L, Mestanza-Peralta M, Lara-Reyes P, Seuc AH, et al. A trial of contraceptive methods in women with systemic lupus erythematosus. N Engl J Med. 2005;353:2539–49. - PubMed
-
- Petri M, Kim MY, Kalunian KC, Grossman J, Hahn BH, Sammaritano LR, et al. Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med. 2005;353:2550–8. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous